Conference call regarding Elekta’s Interim Report for May-January 2016/17

STOCKHOLM, February 15, 2017 – Elekta (EKTA-B.ST) will publish its Interim Report for May-January 2016/17 on March 1, as per:

  • The report will be published at 07:30 CET.
  • Elekta will host a telephone conference starting at 10:00 CET with Richard Hausmann, President and CEO and Håkan Bergström, CFO.

To take part in the conference call, please dial in about five minutes in advance.

  • UK dial-in number:      +44 (0) 203 008 98 01
  • US dial-in number:      +1 646 502 51 18
  • Swedish dial-in number: +46 (0) 2 00 88 38 17  

The telephone conference will also be broadcasted live online through the following link (however, in order to ask questions it is necessary to call in): http://event.onlineseminarsolutions.com/r.htm?e=1359272&s=1&k=D733C45D47631CEF4632451586C25F7C  

# # #

For further information, please contact:
Johan Andersson, Director Investor Relations, Elekta AB
Tel: +46 702 100 451, e-mail: johan.andersson@elekta.com
Time zone: CET: Central European Time

Tobias Bülow, Director Financial Communication, Elekta AB
Tel: +46 722 215 017, e-mail: tobias.bulow@elekta.com
Time zone: CET: Central European Time

Frida Johansson , Investor Relations, Elekta AB
Tel: +46 708 667 674, e-mail: frida.johansson@elekta.com
Time zone: CET: Central European Time

About Elekta
Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,600 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm.  www.elekta.com

About Us

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives. Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,400 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.

Subscribe

Documents & Links